1. HLA-DRB1*04 is a novel fetal susceptibility allele in congenital heart block. (22nd February 2011) Authors: Östberg, T; Görgen, S; Salomonsson, S; Ding, B; Eliasson, H; Elfving, Å; Mälarstig, A; Alfredsson, L; Klareskog, L; Hamsten, A; Olsson, T; Padukov, L; Axelsson, T; Gadler, F; Jonzon, A; Sonesson, S E; Kockum, I; Wahren-Herlenius, M Journal: Annals of the rheumatic diseases Issue: Volume 70(2011)Supplement 2 Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunomodulatory drugs can inhibit the extracellular release of HMGB1 from cultured human monocytes. (4th April 2011) Authors: Schierbeck, H; Wähämaa, H; Östberg, T; Andersson, U; Erlandsson Harris, H Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Interleukin 1β and TLR ligands give enhanced cytokine production by their interaction with HMGB1. (4th April 2011) Authors: Sigridur Hreggvidsdottir, H; Wähämaa, H; Östberg, T; Schierbeck, H; Aveberger, A; Klevenvall, L; Andersson, U; Erlandsson Harris, H Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗